1 Section of Respiratory Medicine, Department of Internal Medicine.
3 The Copenhagen General Population Study, and.
Am J Respir Crit Care Med. 2015 Jul 15;192(2):172-81. doi: 10.1164/rccm.201502-0302OC.
Asthma is associated with complications, cardiovascular comorbidities, and higher mortality in some individuals.
To test the hypothesis that, among individuals with asthma, never-smokers have different characteristics and a better prognosis than smokers.
We recruited 94,079 individuals aged 20-100 years from the Copenhagen General Population Study, a prospective cohort study. Among these individuals, 5,691 (6%) had self-reported asthma (2,304 never-smokers, 2,467 former smokers, and 920 current smokers). We examined respiratory symptoms, lung function, and levels of inflammatory and allergic biomarkers in systemic circulation. Furthermore, we assessed prospectively the risk of asthma or chronic obstructive pulmonary disease (COPD) exacerbations, pneumonias, lung cancer, ischemic heart disease, ischemic stroke, and all-cause mortality during 4.5 years of follow-up.
Compared with never-smokers without asthma, individuals with asthma had more respiratory symptoms and airflow limitation and higher levels of inflammatory and allergic biomarkers, which were most pronounced in smokers. Among individuals with asthma compared with never-smokers without asthma, multivariable adjusted hazard ratios for asthma exacerbations were 11 (95% confidence interval: 5.8-22) in never-smokers, 13 (6.2-29) in former smokers, and 18 (8.2-39) in current smokers. The corresponding values for other endpoints were, respectively, 8.9 (2.1-38), 23 (8.8-58), and 36 (12-105) for COPD exacerbations; 1.5 (0.9-2.2), 1.6 (1.0-2.4), and 2.4 (1.6-3.7) for pneumonias; 0.6 (0.1-5.1), 4.0 (1.3-12), and 13 (4.3-41) for lung cancer; 1.2 (0.9-1.6), 1.5 (1.2-2.0), and 2.0 (1.4-2.9) for ischemic heart disease; 1.4 (0.9-2.1), 1.2 (0.8-1.9), and 3.0 (1.7-5.3) for ischemic stroke; and 0.9 (0.6-1.3), 1.5 (1.1-2.0), and 2.7 (1.9-3.7) for all-cause mortality.
Never-smokers with asthma had an increased risk of asthma and COPD exacerbations, and possibly pneumonias. Importantly, the risks for lung cancer, cardiovascular comorbidities, and death were restricted to smokers with asthma. Thus, tobacco smoking was the main explanation for poor prognosis in asthma.
在某些人群中,哮喘与并发症、心血管合并症和更高的死亡率有关。
检验以下假说,即在哮喘患者中,从不吸烟者与吸烟者相比,具有不同的特征和更好的预后。
我们招募了来自哥本哈根普通人群研究的 94079 名年龄在 20-100 岁之间的个体,这是一项前瞻性队列研究。在这些个体中,有 5691 人(6%)报告有哮喘(2304 名从不吸烟者、2467 名前吸烟者和 920 名现吸烟者)。我们检查了呼吸系统症状、肺功能以及全身性循环中炎症和过敏生物标志物的水平。此外,我们前瞻性评估了在 4.5 年的随访期间哮喘或慢性阻塞性肺疾病(COPD)加重、肺炎、肺癌、缺血性心脏病、缺血性中风和全因死亡率的风险。
与无哮喘的从不吸烟者相比,患有哮喘的个体具有更多的呼吸系统症状和气流受限,以及更高水平的炎症和过敏生物标志物,在吸烟者中最为明显。与无哮喘的从不吸烟者相比,哮喘发作的多变量调整风险比在从不吸烟者中为 11(95%置信区间:5.8-22),在以前吸烟者中为 13(6.2-29),在当前吸烟者中为 18(8.2-39)。其他终点的相应值分别为 COPD 加重的 8.9(2.1-38)、23(8.8-58)和 36(12-105);肺炎的 1.5(0.9-2.2)、1.6(1.0-2.4)和 2.4(1.6-3.7);肺癌的 0.6(0.1-5.1)、4.0(1.3-12)和 13(4.3-41);缺血性心脏病的 1.2(0.9-1.6)、1.5(1.2-2.0)和 2.0(1.4-2.9);缺血性中风的 1.4(0.9-2.1)、1.2(0.8-1.9)和 3.0(1.7-5.3);以及全因死亡率的 0.9(0.6-1.3)、1.5(1.1-2.0)和 2.7(1.9-3.7)。
无哮喘的哮喘患者哮喘和 COPD 加重的风险增加,并且可能会增加肺炎的风险。重要的是,肺癌、心血管合并症和死亡的风险仅限于哮喘的吸烟者。因此,吸烟是哮喘不良预后的主要原因。